MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30.

Income Overview

Net Income
-$53,882,000
EPS
-$0.41
Unit: Dollar

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
License and other revenue
0 0 15,000,000 0
Research and development
41,563,000 42,741,000 33,443,000 60,874,000
General and administrative
12,227,000 11,912,000 12,334,000 13,706,000
Loss from operations
-53,790,000 -54,653,000 -30,777,000 -74,580,000
Interest and investment income
3,765,000 4,380,000 7,890,000 3,718,000
Interest expense
2,890,000 2,884,000 2,877,000 2,504,000
Loss on extinguishment of debt
----8,524,250
Other non-operating income (expense), net
-1,810,000 3,592,000 1,026,000 -3,968,000
Loss before income taxes
-54,725,000 -49,565,000 -24,738,000 -110,279,000
Income tax expense
166,000 778,000 1,397,000 1,050,000
Net loss
-54,891,000 -50,343,000 -26,135,000 -111,329,000
Foreign currency translation adjustment
691,000 -479,000 643,000 1,721,000
Unrealized gain on available for sale securities, net of taxes
---397,000
Unrealized (loss) gain on available for sale marketable securities, net of reclassification adjustment and tax
318,000 -5,000 -2,781,000 -
Other comprehensive (loss) income
1,009,000 -484,000 -2,138,000 2,118,000
Total comprehensive loss
-53,882,000 -50,827,000 -28,273,000 -109,211,000
Net loss per ordinary share - basic (in dollars per share)
-0.41 -0.38 -0.2 -0.91
Net loss per ordinary share - diluted (in dollars per share)
-0.41 -0.38 -0.2 -0.91
Weighted average ordinary shares outstanding - basic (in shares)
134,163,492 133,677,405 133,033,541 -211,157,357
Weighted average ordinary shares outstanding - diluted (in shares)
134,163,492 133,677,405 133,033,541 -211,157,357
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Unrealized (loss) gain onavailable for sale...$318,000 Foreign currencytranslation adjustment$691,000 Total comprehensiveloss-$53,882,000 Other comprehensive(loss) income$1,009,000 Net loss-$54,891,000 Income tax expense$166,000 Loss before incometaxes-$54,725,000 Interest and investmentincome$3,765,000 Other non-operatingincome (expense), net-$1,810,000 Interest expense$2,890,000 Loss from operations-$53,790,000 General andadministrative$12,227,000 Research and development$41,563,000

Centessa Pharmaceuticals plc (CNTA)

Centessa Pharmaceuticals plc (CNTA)